FDA Guidelines on First in Class First in Man Compounds Targeting Tumor Bioenergetics from Lab Bench to Clinical Trials - Webinar By GlobalCompliancePanel 2012
23 Aug 2012
Webinar
Key Topics
Review of relevant FDA regulation, guidelines and points to consider for manufacturing and drug product composition
Introduction into nanotechnology drug delivery and needs for improvement
Clinical development planning and path to approvals
Clinical research to support clinical development and protocol preparation for human study working with the FDA
Who should Attend
Regulatory Affairs Managers, Directors and VPs, Formulation Scientists and Researchers, Manufacturing Managers, Directors and VPs, Quality Managers, Directors and VPs, Strategic Planning Managers, Directors and VPs.
Past Events
FDA Guidelines on First in Class First in Man Compounds Targeting Tumor Bioenergetics from Lab Bench to Clinical Trials - Webinar By GlobalCompliancePanel 2012 - 23 Aug 2012, Webinar (31879)
FDA Guidelines on in Class in Man Compounds Targeting Tumor Bioenergetics from Lab Bench to Clinical Trials - Webinar By GlobalCompliancePanel 2026
Important
Please, check "FDA Guidelines on in Class in Man Compounds Targeting Tumor Bioenergetics from Lab Bench to Clinical Trials - Webinar By GlobalCompliancePanel" official website for possible changes, before making any traveling arrangements
